Cell Therapy Blog

Business news and analysis for executives in the cell therapy and regenerative medicine industry.

Pages

Home
About Us
About the Blog
Cell Therapy Consulting
LinkedIn Cell Therapy Industry Group
Cell Therapy Videos
@celltherapy on Twitter
Cell Therapy Education and Training

Showing posts with label twitter. Show all posts

Saturday, January 3, 2009

Twitter Away Your 2009!

http://twitter.com/celltherapy

Posted by Lee Buckler at 1:05 PM 0 comments

Email This BlogThis!Share to X Share to Facebook Share to Pinterest

Labels: cell therapy, twitter

Older Posts Home

Subscribe to: Posts (Atom)

About the CellTherapyBlog

The blog covers the cell therapy industry.

Follow this blog on Twitter: @celltherapyblog

Follow Lee on Twitter: @celltherapy

Blog Archive

▼ 2022 (1)
- ▼ February (1)
  - Cell and Gene Therapy Industry - Source Material S...

► 2021 (6)
- ► December (1)
- ► November (3)
- ► August (1)
- ► July (1)

► 2017 (1)
- ► January (1)

► 2015 (4)
- ► May (1)
- ► April (1)
- ► January (2)

► 2014 (9)
- ► December (1)
- ► November (1)
- ► October (1)
- ► July (1)
- ► May (2)
- ► April (1)
- ► February (1)
- ► January (1)

► 2013 (7)
- ► December (1)
- ► June (1)
- ► April (2)
- ► January (3)

► 2012 (26)
- ► December (3)
- ► November (4)
- ► October (4)
- ► September (3)
- ► August (3)
- ► July (3)
- ► June (1)
- ► May (2)
- ► April (1)
- ► March (2)

► 2011 (18)
- ► December (5)
- ► November (2)
- ► September (4)
- ► August (1)
- ► July (2)
- ► June (2)
- ► February (1)
- ► January (1)

► 2010 (9)
- ► September (1)
- ► August (1)
- ► July (1)
- ► June (1)
- ► May (2)
- ► April (2)
- ► March (1)

► 2009 (38)
- ► September (1)
- ► July (3)
- ► June (4)
- ► May (2)
- ► April (7)
- ► March (7)
- ► February (8)
- ► January (6)

► 2008 (26)
- ► December (5)
- ► November (8)
- ► October (1)
- ► September (3)
- ► August (4)
- ► July (1)
- ► June (4)

Labels

#BTS14 (1)
#BTS15 (1)
#BTS23 (1)
2013 EBD Biotech Showcase (1)
2013 Regenerative Medicine Industry Report (1)
2014 (1)
21 CFR Part 1271 (1)
21st Century Cures Act (1)
AABB (1)
Aastrom (9)
ABH (1)
Achilles tendinosis (1)
ACT (8)
Adaptimmune (1)
Aderans (1)
adipose stem cells (1)
Adistem (1)
Advanced Cell Technology (2)
AfC (1)
aging skin (1)
Aldagen (2)
Alliance for Regenerative Medicine (4)
American Recovery and Reinvestment Act (1)
American Stem Cell (1)
AmnioGraft (1)
Amorcyte (2)
AmStem (3)
androgenetic alopecia (1)
Andy Grove (1)
Angel Biotech (2)
Angel Biotechnology (1)
Angioblast (1)
Anna French (1)
Annual Cell & Gene Therapy World Asia (1)
annual industry report (1)
Applied BioSystems (1)
Apptec (1)
Apptec Laboratories (1)
Arbios (1)
Arblast (1)
Argos Therapeutics (2)
ARM (3)
ARRA (1)
Arteriocyte (2)
ASCTA (1)
ASGT (1)
Ashish Verma (1)
ASRM (1)
Athersys (11)
ATHX (2)
ATMP (1)
autologous cell therapy (8)
AuxoCell (1)
Avax (1)
Avita (1)
Baxter (1)
Bellicum (1)
Bill Fodor (1)
Bill Maris (1)
BIO (2)
Bio-Matrix (3)
biobusiness (1)
BioBusiness.tv (3)
Biocision (1)
Biocompatibles (1)
BioE (1)
Bioheart (9)
BioKorea (1)
BioLife (6)
BioLife Soutions (5)
Bionet (1)
bioprocess (1)
bioprocess international (1)
bioprocessing (3)
bioproduction (1)
bioreactor (1)
BioSafe (2)
BioSante (1)
biotech (2)
Biotech Showcase (1)
biotech tax credit (1)
biotechnology (1)
BioTime (4)
blood centers (1)
blood-derived cells (1)
BLUE (1)
bluebird bio (1)
BMS (1)
Brooks Automation (1)
Burrill Report (1)
c ell therapy (1)
California Institute for Regenerative Medicine (1)
Canada (1)
Canadian Stem Cell Foundation (1)
cancer immunotherapy (1)
cancer stem cells (1)
cardiac (1)
cardiac cell therapy (2)
cardiac disease (1)
Cardio3 (2)
cardiovascular (2)
cardiovascular cell therapy (1)
career (1)
Caridian BCT (1)
Carticel (1)
CAT (1)
CBAI (3)
CBER (3)
CCRM (1)
CELG (1)
Celgene (4)
cell collections (1)
cell counts (2)
cell dose (1)
Cell Genesys (4)
cell imaging (1)
Cell Medica (2)
Cell Sense (2)
cell therapies (5)
Cell Therapies Pty (1)
cell therapy (65)
cell therapy bioprocessing (1)
Cell Therapy Blog (1)
cell therapy business (1)
cell therapy careers (1)
cell therapy clinical trials (2)
cell therapy commercialization (3)
cell therapy companies (2)
cell therapy conferences (1)
Cell Therapy Group (10)
cell therapy index (2)
cell therapy industry (19)
cell therapy investment (3)
cell therapy investors (1)
cell therapy jobs (1)
cell therapy manufacturing (3)
cell therapy market (3)
cell therapy portfolio (4)
cell therapy product approvals (1)
cell therapy products (4)
cell therapy recruiting (1)
cell therapy technologies (1)
cell therapy trial costs (1)
cell therapy trials (4)
cell washing (1)
cell-based immunotherapy (2)
Celladon (1)
CellBead (1)
cellcotec (1)
CellCyte Genetics (1)
CELLebrity Doctors (1)
CELLebrity Doctors Calendar (1)
Cellerant (1)
Cellerix (1)
CellGenesys (1)
CellGenix (1)
CellMed (1)
cellometer (2)
celltherapyblog (1)
celltherapycompany.com (1)
celltherapymanufacturing.com (1)
celltherapypatents.com (1)
CellTran (2)
Cellular Dynamics (2)
cellular imaging (1)
cellular immunotherapy (2)
cellular therapies (2)
cellular therapy (2)
cellutions summit (1)
Celprogen (1)
Celsense (4)
Centocor (1)
central nervous system (1)
Ceregene (1)
Cesca Therapeutics (1)
cGMP (1)
cGTP (1)
CHA Biotech (3)
charity (1)
chase community giving (1)
China Cord Blood (1)
ChondroCelect (2)
chris mason (1)
Christopher Centeno (2)
CIRM (8)
clinical trial bias (1)
clinical trial costs (1)
clinical trial data (1)
clinical trials (2)
clinicaltrials.gov (1)
Cognate BioServices (1)
commercial products (1)
commercialization (1)
Commercialization of Regenerative Medicine Summit (1)
commercializing regenerative medicine (1)
Committee for Advanced Therapies (1)
communications (1)
conditional approval (1)
consulting (1)
CoolBox (1)
CoolCell (1)
CoolRack (1)
CoolStation (1)
Cord Blood Registry (1)
Cordlife (2)
Countess (1)
court ruling (1)
Cryo-Save (1)
cryopreservation (2)
Cryoskin (2)
CUR (1)
Cyntellect (1)
Cytori (17)
CYTX (2)
D-Finitive Technologies (1)
data management (1)
David A. Brindley (1)
David A. Steenblock (1)
david j. mooney (1)
David Steenblock (1)
Davinci (1)
Dendreon (15)
dendritic cell vaccine (1)
Dermagraft (2)
dermal cup sheath cells (1)
dermal sheath cup cells (1)
Diabecell (1)
diabetes (1)
DMSO (1)
domains (1)
Dow Jones (2)
Dr. Steenblock (1)
easyCyte (1)
EBD Biotech Showcase (1)
EMA (1)
embryonic stem cell (1)
embryonic stem cells (1)
EnsuraSep (1)
Epicel (1)
ERA consulting (1)
ERYtech (2)
Essential Pharma (1)
Eufets (3)
evidence-based medicine (1)
EyeCyte (1)
FACT (1)
FC-Pharmicell (1)
FDA (16)
FDA CBER (1)
fibroblasts (2)
Fibrocell (2)
financial analysis (1)
financing (2)
Florida Biologix (1)
Fortune (1)
Founder CEO (1)
Fujifilm Life Science (1)
funding (1)
fundraising for stem cell research (1)
Fusionary (1)
future science group. social network (1)
gamida cell (1)
GamidaCell (2)
Garnet (1)
GE Healthcare (5)
Geeta Shroff (1)
GEN (1)
gene therapies (1)
gene therapy (3)
gene-mediated cell therapy (1)
Genzyme (7)
Geron (6)
GlaxoSmithkline (1)
Google (1)
Google Venture (1)
GRASPA (1)
GSK (1)
GSRAC (1)
hair follicle cells (1)
hair loss (1)
hamocytometer (1)
Harvard Stem Cell Institute (1)
Harvest Technologies (2)
Heartcelligram (1)
Hearticellgram Laviv (1)
Hemacell (1)
Hemacord (1)
HemaTrue (1)
Hemostemix (1)
HepaLife (2)
HepaLife Technologies (2)
hESCs (1)
Histogen (3)
Histostem (1)
Hospira (1)
IBM (1)
ICCBA (1)
ICES13 (1)
ICMS (1)
illegal cell therapies (2)
Immunocellular (3)
immunotherapy (1)
IMPACT (1)
INCELL (2)
informa (1)
injunction (1)
injunction litigation (1)
innovacell (1)
Innovacell Biotechnologie (1)
Intellicell Biosciences (2)
Intercytex (3)
International Stem Cell Corp (1)
Introgen (1)
investment (2)
Invitrogen (3)
iPS (1)
IRX (1)
ISBT128 (1)
ISCO (9)
ISCT (13)
Isolagen (4)
ISSCR (7)
ISSCT (1)
iZumi (2)
Japan (4)
JCR Pharmaceuticals (2)
JDRF (1)
JnJ (2)
Johnson and Johnson (2)
Juno Therapeutics (1)
JW Creagene (1)
K L Gates (1)
KeraCure (2)
Key Biologics (1)
KFDA (2)
Kiadis (2)
KITE (1)
Kite Pharma (1)
Kleiner Perkins (1)
Korea (1)
Korean FDA (1)
laboratory (1)
lancet (1)
late stage (2)
lawsuit (1)
LCT (2)
LeBlanc (1)
Lee Buckler (3)
Life Technologies (4)
LinkedIn Cell Therapy Indusry Group (2)
LinkedIn Cell Therapy Industry Group (1)
Living Cell Technologies (3)
LLC (1)
long tail (2)
Lonza (4)
Luc Gervais (1)
Lucanix (1)
Luke Timmerman (1)
MACI (1)
manufacturing (3)
market index (1)
marketing (1)
Maxcyte (3)
MedCell Bioscience (1)
medical tourism (1)
Medistem (2)
MediVet-America (2)
Memgen (1)
mentoring (1)
Mesoblast (6)
Mesolast (1)
MicroIslet (3)
Millipore (2)
Miltenyi (3)
MolMed (3)
MRI (1)
MSB (1)
MSC (1)
MultiCell Technologies (1)
MultiStem (2)
Mvax (1)
Myskin (2)
NASDAQ (2)
NECC (1)
NeoStem (8)
NeuralStem (7)
NeuroGeneration (1)
NeuroNova (1)
Neurotech (1)
Newlink Genetics (1)
NIH (1)
non-compliant cell therapies (2)
Northwest Bio (1)
Northwest Biotherapeutics (2)
Novartis (2)
NovaRx (3)
Novocell (5)
Novovell (1)
NucleoCounter (2)
NuTech MediWorld (1)
Nuvasis (2)
NuVasive (2)
NYBC (1)
Obama (1)
oncology (1)
Onyvax (1)
Opexa (6)
OrCel (1)
Organogenesis (2)
Ortho Biotech (1)
OSIR (1)
Osiris (15)
Osteocel (3)
Osteotech (1)
outperform (1)
oxford (1)
Pacell (1)
PacificCord (1)
PACT (1)
Pall (1)
pattern baldness (1)
Perkin Elmer (2)
personalized medicine (2)
personalized medicine pharma (1)
Pfizer (6)
Phacilitate (2)
pharma (2)
pharma industry (2)
PharmaCell (2)
pharmceutical (1)
Pharmicell (2)
phase 2/3 (2)
phase 3 (2)
phase II/III (2)
phase III (4)
phase III trials (1)
Piercell (1)
pivotal (3)
Pluristem (8)
PMDA (1)
Prima BioMed (2)
PrimaBiomed (1)
Prochmal (1)
Prochon Biotech (1)
Prochymal (6)
product nomenclature (1)
Progenitor (7)
Progenitor Cell Therapy (5)
Prokera (1)
proprietary names (1)
prostate cancer (1)
Proteus Venture (2)
ProtoKinetix (1)
Provenge (8)
PSTI (1)
public companies (4)
public relations (1)
Q Therapeutics (1)
Quantum Immunologics (1)
RCH-01 (1)
Recell (1)
Recover Act (1)
regen industry (1)
regenerative medcine (4)
regenerative medicine (21)
regenerative medicine careers (1)
regenerative medicine conferences (1)
regenerative medicine foundation (1)
regenerative medicine industry (6)
Regenerative Medicine Industry Briefing (1)
regenerative medicine jobs (1)
regenerative medicine recruiting (1)
regenerative sciences (6)
regenerativemedicinepatents.com (1)
Regenetech (1)
regenexx (9)
regenmed (3)
RegenMedNet (1)
Regnocyte (1)
regulation (2)
Rejuvenation Research (1)
ReNeuron (3)
REPCF (3)
RepliCel (5)
RepliCel Life Sciences (4)
reproducibility (1)
rich versus king (1)
RNL Bio (1)
Roche (1)
RP (1)
RRY Publications (1)
RWD (1)
RWE (1)
Sabrina Cohen (1)
Sabrina Cohen Foundation (1)
Salesforce (1)
sample handling (1)
Sampling Science (1)
SanBio (1)
Sangamo (1)
sanofi (1)
Sanofi-Aventis Stratetech (1)
SBIR (1)
Select Biosciences (1)
Sernova (1)
Shire (1)
Shiseido (4)
Sigma-Aldrich (2)
small business (1)
social media (2)
Somatic Cell Therapy (1)
Somatic Cell Therapy Symposium (1)
source material (1)
South Korea (1)
SP500 (1)
spin-outs (1)
Standard and Poor's (1)
standardization (1)
stem cell (5)
stem cell careers (1)
stem cell clinics (1)
stem cell domains (1)
stem cell foundation (1)
stem cell jobs (1)
stem cell network (1)
Stem Cell Partners (1)
stem cell research (2)
Stem Cell Sciences (5)
stem cell therapy (1)
stem cell tourism (2)
stem cell transplant (1)
stem cell treatment (1)
stem cell treatments (1)
stem cells (10)
Stem Cells Inc (4)
Stem Cells Inc. (1)
stemcell (1)
stemcelldoc (1)
StemCellMD (1)
StemCells Inc (4)
StemCyte (2)
Stemedica (2)
Stempeutics (1)
Stephen Minger (1)
stimulus funding (1)
stock performance (1)
Stratatech (2)
StrokeDoctor (1)
stromal vascular fraction (1)
sun-damaged skin (1)
SVF (2)
T cells (1)
t2cure (2)
Taiwan (1)
Takeda (2)
TAP (1)
TCA (1)
tendinosis (1)
Tengion (3)
TERMIS (1)
teva (2)
the Niche (1)
thecelltherapycompany.com (1)
TheraCell (1)
theragnostics (2)
Therakos (2)
theranostics (2)
Therapeutic Discovery Project Credit (1)
ThermoGenesis (5)
theStreet.com (1)
TiGenix (4)
tissue engineering (2)
Tissue Genesis (2)
Toucan (1)
Trinity (1)
Trump (1)
TVAX (1)
twitter (1)
TxCell (1)
type 1 collagen (1)
Uluru (1)
United States (1)
untitled letter (1)
USA (1)
USP (1)
UVAR XTS (1)
VCEL (1)
venture capital (2)
Vericel (1)
Vet-Stem (2)
Viacord (1)
video content (1)
violation (1)
VIRxSYS (1)
Wall Street Journal (1)
warning letter (1)
Wave Biotech (1)
Webby (1)
William Fodor (1)
Wired (1)
Wuxi (1)
Wuxi Apptec (1)
Wuxi-Apptec (1)
www.cellebritydocscalendar.com (1)
Xcell-Center (1)
Xconomy (1)
York Pharma (4)

@celltherapy on Twitter

Subscribe by Email

Your email address:

Powered by FeedBlitz

Subscribe To Cell Therapy Blog

Posts

Atom

Posts

All Comments

Atom

All Comments

Twitter Updates

follow me on Twitter

PostRank

About Lee

Lee Buckler: Lee is Cell Therapy Blog's founder and primary blogger. Lee is an executive, advisor, blogger, analyst, speaker, author and entrepreneur in the cell therapy industry. Lee is currently at RepliCel Life Sciences Inc. He was previously the founder and managing director of Cell Therapy Group – a consulting firm focused on the cell therapy and cell-based regenerative medicine industry. His is the founder/owner of the LinkedIn Cell Therapy Industry Group and the LinkedIn Cell & Gene Therapy / Regenerative Medicine Careers & Recruiting Group.

View my complete profile

Cell Therapy Blog

Loading...

LinkedIn Profile

Simple theme. Powered by Blogger.